BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15516801)

  • 1. [Wilson's disease and its pharmacological treatment].
    Hayashi H; Suzuki R; Wakusawa S
    Yakugaku Zasshi; 2004 Nov; 124(11):711-24. PubMed ID: 15516801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilson's disease: physiopathological, clinical and therapeutic considerations].
    Pérez-Aguilar F
    Gastroenterol Hepatol; 2003 Jan; 26(1):42-51. PubMed ID: 12525328
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wilsons disease].
    Mareček Z; Brůha R
    Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
    Palumbo E
    Recenti Prog Med; 2008 Nov; 99(11):561-4. PubMed ID: 19209540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilson's disease: an update.
    Das SK; Ray K
    Nat Clin Pract Neurol; 2006 Sep; 2(9):482-93. PubMed ID: 16932613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH; Stremmel W
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Wilson's disease: a comprehensive review.
    Mak CM; Lam CW
    Crit Rev Clin Lab Sci; 2008; 45(3):263-90. PubMed ID: 18568852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilson's disease.
    Loudianos G; Gitlin JD
    Semin Liver Dis; 2000; 20(3):353-64. PubMed ID: 11076401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wilson disease].
    Shimizu N
    Nihon Rinsho; 2004 Jan; 62 Suppl():399-403. PubMed ID: 15011394
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics.
    Aaseth J; Flaten TP; Andersen O
    Scand J Gastroenterol; 2007 Jun; 42(6):673-81. PubMed ID: 17505988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
    Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
    Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.